Home > Riviste > Minerva Urology and Nephrology > Fascicoli precedenti > Minerva Urologica e Nefrologica 2019 October;71(5) > Minerva Urologica e Nefrologica 2019 October;71(5):531-6

ULTIMO FASCICOLO
 

JOURNAL TOOLS

Opzioni di pubblicazione
eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Permessi
Per citare questo articolo
Share

 

ORIGINAL ARTICLE   Free accessfree

Minerva Urologica e Nefrologica 2019 October;71(5):531-6

DOI: 10.23736/S0393-2249.18.03243-5

Copyright © 2018 EDIZIONI MINERVA MEDICA

lingua: Inglese

External validation of Imamura nomogram as a tool to predict preoperatively laser semi-rigid ureterolithotripsy outcomes

Cosimo DE NUNZIO 1 , Mariangela BELLANGINO 1, Olivia A. VOGLINO 1, Valeria BALDASSARRI 1, Riccardo LOMBARDO 1, Matteo PIGNATELLI 2, Giorgia TEMA 1, Eva BERARDI 2, Antonio CREMONA 2, Andrea TUBARO 1

1 Department of Urology, Sant’Andrea Hospital, Sapienza University, Rome, Italy; 2 Department of Radiology, Sant’Andrea Hospital, Sapienza University, Rome, Italy



BACKGROUND: We aimed to validate Imamura nomogram for prediction of stone free rate in patients undergoing ureterolithotripsy (ULT).
METHODS: From January 2013 to June 2016, patients undergoing laser semi-rigid ULT were prospectively enrolled at our center. All patients were preoperatively assessed with clinical history, blood samples, uranalysis and non-contrast enhanced computed tomography (CT). Treatment efficacy was assessed 1 month later by non-contrast enhanced CT. ROC curve was used to evaluate the performance characteristics of Imamura nomogram.
RESULTS: Overall, we enrolled 275 patients. Median age was 55 years (IQR: 46/64), median length of stone was 9.8 mm (IQR: 7.5/12). Pyuria was detected in 6/275 (2.1%) patients. Stones were located at ureteropelvic junction in 55/275 (19%) patients, proximal ureter in 74/275 (26%) patients, middle and distal ureter in 66/275 (24%) patients and 82/275 (30%) patients, respectively. At 1-month follow-up, 209/275 (76%) patients were stone free. Imamura nomogram presented an AUC of 0.67 (95% CI: 0.580-0.761) for the prediction of stone free rate. At the best cut-off value of 75%, sensitivity was 76%, specificity was 55%, positive predictive value (PPV) was 83% and negative predictive value was 45%.
CONCLUSIONS: We firstly validated Imamura nomogram in a European cohort study. It proved a reasonable accuracy (area under curve: 0.67) and a good PPV (83%). Further studies should confirm our results to support the routine clinical use of Imamura nomogram as a tool to predict ULT outcomes.


KEY WORDS: Nomograms; Ureteral calculi; Lithotripsy; Patient outcome assessment

inizio pagina